Author:
Taieb J.,Sinicrope F.A.,Pederson L.,Lonardi S.,Alberts S.R.,George T.J.,Yothers G.,Van Cutsem E.,Saltz L.,Ogino S.,Kerr R.,Yoshino T.,Goldberg R.M.,André T.,Laurent-Puig P.,Shi Q.
Reference27 articles.
1. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer;Van Cutsem;Ann Oncol,2016
2. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Cervantes;Ann Oncol,2023
3. The evolving biomarker landscape for treatment selection in metastatic colorectal cancer;Taieb;Drugs,2019
4. Colon cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology;Benson;J Natl Compr Cancer Netw,2021
5. Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer;Kopetz;N Engl J Med,2019
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献